Literature DB >> 20724003

Decreased self-reported arousal in schizophrenia during aversive picture viewing compared to bipolar disorder and healthy controls.

Sofie R Aminoff1, Jimmy Jensen, Trine V Lagerberg, Ole A Andreassen, Ingrid Melle.   

Abstract

Both schizophrenia (SCZ) and bipolar disorder (BD) are associated with disturbances in emotion processing. Previous studies suggest that patients with SCZ assess unpleasant pictures as less arousing than healthy controls (HC), while patients with BD assess neutral pictures as more arousing than HC. No previous studies have investigated whether there is a difference in emotional response across all three groups. Our aim was to explore whether there was a difference in the evaluation of valence and in arousal between SCZ, BD and HC for aversive and neutral pictures. We showed 72 pictures (neutral, non-socially aversive and socially aversive) from the International Affective Picture System (IAPS) to 347 subjects. There was a clear interaction effect between the diagnostic group and increasing picture aversiveness for both valence and arousal. There were no significant differences in valence ratings between the different groups or in arousal ratings on any type of stimuli between BD patients and HC. However, SCZ patients reported significantly lower arousal for aversive stimuli, particularly with a social content, when compared to BD patients and HC. This was more pronounced in females. The presence of lifetime psychotic symptoms did not influence emotional responses.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20724003     DOI: 10.1016/j.psychres.2010.07.026

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

1.  Facial emotion recognition in first-episode schizophrenia and bipolar disorder with psychosis.

Authors:  Alexander R Daros; Anthony C Ruocco; James L Reilly; Margret S H Harris; John A Sweeney
Journal:  Schizophr Res       Date:  2014-01-21       Impact factor: 4.939

2.  Looking at the other side of the coin: a meta-analysis of self-reported emotional arousal in people with schizophrenia.

Authors:  Katiah Llerena; Gregory P Strauss; Alex S Cohen
Journal:  Schizophr Res       Date:  2012-10-03       Impact factor: 4.939

3.  The impact of social content and negative symptoms on affective ratings in schizophrenia.

Authors:  Anjuli S Bodapati; Ellen S Herbener
Journal:  Psychiatry Res       Date:  2014-04-05       Impact factor: 3.222

4.  Trait and state positive emotional experience in schizophrenia: a meta-analysis.

Authors:  Chao Yan; Yuan Cao; Yang Zhang; Li-Ling Song; Eric F C Cheung; Raymond C K Chan
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

5.  Eye gaze and facial displays of emotion during emotional film clips in remitted patients with bipolar disorder.

Authors:  Hanne Lie Kjærstad; Caroline Kamp Jørgensen; Ingrid Broch-Due; Lars Vedel Kessing; Kamilla Miskowiak
Journal:  Eur Psychiatry       Date:  2020-02-27       Impact factor: 5.361

6.  From semantics to feelings: how do individuals with schizophrenia rate the emotional valence of words?

Authors:  Ana P Pinheiro; Robert W McCarley; Elizabeth Thompson; Oscar F Gonçalves; Margaret Niznikiewicz
Journal:  Schizophr Res Treatment       Date:  2012-06-06

7.  Assessing brain structural associations with working-memory related brain patterns in schizophrenia and healthy controls using linked independent component analysis.

Authors:  Christine Lycke Brandt; Nhat Trung Doan; Siren Tønnesen; Ingrid Agartz; Kenneth Hugdahl; Ingrid Melle; Ole A Andreassen; Lars T Westlye
Journal:  Neuroimage Clin       Date:  2015-08-21       Impact factor: 4.881

8.  A common NTRK2 variant is associated with emotional arousal and brain white-matter integrity in healthy young subjects.

Authors:  K Spalek; D Coynel; V Freytag; F Hartmann; A Heck; A Milnik; D de Quervain; A Papassotiropoulos
Journal:  Transl Psychiatry       Date:  2016-03-15       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.